Free cancer care alone won’t help India fight cancer
- November 21, 2023
- Posted by: OptimizeIAS Team
- Category: DPN Topics
No Comments
Free cancer care alone won’t help India fight cancer
Subject : Science and Tech
Section: Health
Context:
- By 2040, according to one estimate, 20 lakh people a year will be diagnosed with cancer in India.
Details:
- Cancer is already the third leading cause of death in India.
- A June 2023 study reported that even among patients with PMJAY or other state-sponsored health insurance coverage, cancer treatment rendered catastrophic health expenses in more than 80% and impoverishment in more than 60% of people.
- The financial burden increases by adding to the direct and/or indirect Out-of-pocket expenditure (OOPE).
- Direct medical OOPE includes doctor’s consultation fees, cost of medicines, and medical tests, and direct non-medical OOPE includes costs of transport, accommodation, and food for people travelling to larger cities for treatment. Indirect OOPE accounts for the loss of productive hours and/or income.
Government efforts to reduce the financial burden:
- In 2012, the Haryana government made transport for patients with cancer and one caregiver in public buses from their places of residence to their places of treatment free.
- In Kerala, patients with cancer are eligible for a 50% concession on public bus tickets.
- In 2017, Delhi launched the Arogya Kosh scheme to reduce the burden on public health centres and avoid treatment delays. Here, residents of Delhi making less than Rs 3 lakh a year are eligible to get certain tests, like ultrasound and CT scans, in private health centres for free.
- Haryana, Tripura, and Kerala have also floated a ‘cancer pension’ to financially assist patients with advanced-stage cancer: Rs 2,500 per month in Haryana and Rs 1,000 in Tripura and Kerala.
National Cancer Grid (NCG):
- The National Cancer Grid (NCG) is an initiative of the Government of India through the Department of Atomic Energy and its grant-in-aid institution, the Tata Memorial Centre, to create a network of cancer centres, research institutes, patient groups and charitable institutions across India with the objective of developing uniform standards of patient care for prevention, diagnosis, and treatment of cancer; providing specialized training and education in oncology and facilitating collaborative basic, translational and clinical research in cancer.
National Cancer Registry Programme (NCRP):
- For a database of cancer cases, the National Cancer Registry Programme (NCRP) was initiated in 1982 by ICMR, which gives a picture of the magnitude and patterns of cancer.
- There are two types of registries; Population Based Cancer Registry and Hospital Based Cancer Registries, which were started in January 1982.
GOALS & OBJECTIVES OF NCCP
- Primary prevention of cancers by health education especially regarding hazards of tobacco consumption and the necessity of genital hygiene for the prevention of cervical cancer.
- Secondary prevention i.e. early detection and diagnosis of cancers, for example, cancer of the cervix, breast and oro-pharyngeal cancer by screening methods and patients’ education on self-examination methods.
- Strengthening of existing cancer treatment facilities, which are woefully inadequate.
- Palliative care in the terminal stage of the cancer.
Other initiatives:
- National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) is being implemented under the National Health Mission (NHM) for up-to-the-district level activities.
- Under the ambit of Ayushman Bharat, Pradhan Mantri Jan ArogyaYojana (PM-JAY) is being implemented to reduce the financial burden for poor and vulnerable groups arising out of catastrophic hospital episodes and to provide access to quality health services.
- National Pharmaceutical Pricing Authority (NPPA) launched a Pilot on Trade Margin Rationalisation for 42 anti-cancer drugs in February 2020 as a step towards making healthcare more affordable for suffering patients. This led to a reduction in the prices of drugs.
Source: The Hindu